Min Ma

597 total citations
34 papers, 470 citations indexed

About

Min Ma is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Min Ma has authored 34 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Min Ma's work include Microbial Natural Products and Biosynthesis (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immune cells in cancer (3 papers). Min Ma is often cited by papers focused on Microbial Natural Products and Biosynthesis (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immune cells in cancer (3 papers). Min Ma collaborates with scholars based in China, Lebanon and United Kingdom. Min Ma's co-authors include Chaohui Zuo, Wei Huang, Xiahui Lin, Man Xia, Rui Zhang, Rongxin Chen, Guijuan Zhang, Zhengzhi Wu, Dan Qiu and Ruirui Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Nanoscale.

In The Last Decade

Min Ma

32 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min Ma China 15 207 112 104 89 66 34 470
Jingbo Yang China 15 310 1.5× 70 0.6× 68 0.7× 80 0.9× 56 0.8× 28 605
Ying Luo China 14 374 1.8× 89 0.8× 76 0.7× 116 1.3× 78 1.2× 44 751
Bing Xia China 13 219 1.1× 127 1.1× 69 0.7× 56 0.6× 41 0.6× 51 505
Zhan‐Qi Cao China 10 275 1.3× 112 1.0× 110 1.1× 104 1.2× 45 0.7× 14 528
Hisakazu Komori Japan 14 243 1.2× 115 1.0× 58 0.6× 92 1.0× 33 0.5× 26 544
Qing Guo China 14 205 1.0× 76 0.7× 172 1.7× 64 0.7× 32 0.5× 30 570
Ningwei Zhao China 15 308 1.5× 51 0.5× 79 0.8× 73 0.8× 53 0.8× 29 565
Caiguo Ye China 11 233 1.1× 82 0.7× 42 0.4× 142 1.6× 42 0.6× 16 390
Dandan Jiang China 13 240 1.2× 78 0.7× 102 1.0× 63 0.7× 20 0.3× 29 449

Countries citing papers authored by Min Ma

Since Specialization
Citations

This map shows the geographic impact of Min Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Ma more than expected).

Fields of papers citing papers by Min Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Ma. The network helps show where Min Ma may publish in the future.

Co-authorship network of co-authors of Min Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Min Ma. A scholar is included among the top collaborators of Min Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Ma. Min Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saleh, Marwa, et al.. (2025). Feasibility of robotic surgery in elderly patients with rectal cancer: a meta-analysis. Journal of Robotic Surgery. 19(1). 50–50.
2.
Ma, Min, Liang Li, Chuan Huang, et al.. (2024). Lymphatic endothelial cell-mediated accumulation of CD177 + Treg cells suppresses antitumor immunity in human esophageal squamous cell carcinoma. OncoImmunology. 13(1). 2327692–2327692. 9 indexed citations
3.
Ma, Xinyi, et al.. (2023). Kaempferol induces mitochondrial dysfunction and mitophagy by activating the LKB1/AMPK/MFF pathway in breast precancerous lesions. Phytotherapy Research. 37(8). 3602–3616. 14 indexed citations
4.
Huang, Wei, et al.. (2023). Biomedical statistics study on the correlation between peripheral blood follicular helper T cell subsets and primary Sjogren's syndrome. Cellular and Molecular Biology. 69(2). 121–125. 1 indexed citations
5.
Wang, Mengting, et al.. (2022). Development and validation of a nomogram for predicting pelvic lymph node metastasis and prognosis in patients with cervical cancer. Frontiers in Oncology. 12. 952347–952347. 5 indexed citations
6.
Zhang, Junyan, Zhongxiu Chen, Min Ma, & Yong He. (2022). Soluble ST2 in coronary artery disease: Clinical biomarkers and treatment guidance. Frontiers in Cardiovascular Medicine. 9. 924461–924461. 20 indexed citations
7.
Qiu, Dan, Guijuan Zhang, Xinyi Ma, et al.. (2022). Prospects of Immunotherapy for Triple-Negative Breast Cancer. Frontiers in Oncology. 11. 797092–797092. 28 indexed citations
9.
Qiu, Dan, et al.. (2021). To explore immune synergistic function of Quercetin in inhibiting breast cancer cells. Cancer Cell International. 21(1). 632–632. 34 indexed citations
10.
Tao, Cheng, Jian Chen, Xiaofei Huang, et al.. (2020). CT1-3, a novel magnolol-sulforaphane hybrid suppresses tumorigenesis through inducing mitochondria-mediated apoptosis and inhibiting epithelial mesenchymal transition. European Journal of Medicinal Chemistry. 199. 112441–112441. 17 indexed citations
11.
Chen, Rongxin, Yuhong Gan, Ningling Ge, et al.. (2019). A new prediction model for prognosis of patients with intermediate-stage HCC after conventional transarterial chemoembolization: an internally validated study. Journal of Cancer. 10(26). 6535–6542. 5 indexed citations
12.
Fan, Xiaotong, Ruizhen Tian, Tingting Wang, et al.. (2018). An ultrathin iron-porphyrin based nanocapsule with high peroxidase-like activity for highly sensitive glucose detection. Nanoscale. 10(47). 22155–22160. 33 indexed citations
13.
Dong, Gang, Min Ma, Xiahui Lin, et al.. (2018). Treatment-damaged hepatocellular carcinoma promotes activities of hepatic stellate cells and fibrosis through GDF15. Experimental Cell Research. 370(2). 468–477. 22 indexed citations
14.
Ma, Min, et al.. (2018). IL-17 inhibits the accumulation of myeloid-derived suppressor cells in breast cancer via activating STAT3. International Immunopharmacology. 59. 148–156. 38 indexed citations
15.
Zuo, Chaohui, Darong Yang, Nianli Liu, et al.. (2018). Celecoxib suppresses proliferation and metastasis of pancreatic cancer cells by down-regulating STAT3 / NF-kB and L1CAM activities. Pancreatology. 18(3). 328–333. 39 indexed citations
16.
Liu, Zhuo, Min Ma, Lei Yan, et al.. (2018). miR-370 regulates ISG15 expression and influences IFN-α sensitivity in hepatocellular carcinoma cells. Cancer Biomarkers. 22(3). 453–466. 17 indexed citations
17.
Zuo, Chaohui, et al.. (2016). ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system. Oncotarget. 7(45). 74393–74409. 41 indexed citations
18.
Liu, Weiying, et al.. (2015). The importance of start codon of nosM in nosiheptide production. Chinese Journal of Natural Medicines. 13(11). 854–860. 5 indexed citations
20.
Shan, Qiuli, et al.. (2014). Augmented atherogenesis in ApoE-null mice co-exposed to polychlorinated biphenyls and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology. 276(2). 136–146. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026